Section Arrow
Quote
CNTA.NASDAQ
- Centessa Pharmaceuticals plc
Quotes are at least 15-min delayed:2026/04/22 11:52 EDT
Regular Hours
Last
 39.5
+0.01 (+0.03%)
Day High 
39.54 
Prev. Close
39.49 
1-M High
40.26 
Volume 
2.68M 
Bid
39.49
Ask
39.5
Day Low
39.45 
Open
39.53 
1-M Low
25.17 
Market Cap 
6.11B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 39.57 
20-SMA 36.8 
50-SMA 30.44 
52-W High 40.26 
52-W Low 10.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.46/-1.64
Enterprise Value
6.23B
Balance Sheet
Book Value Per Share
3.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
15.00M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.2138+0.017+8.64%-- 
REPLReplimune Group2.165+0.305+16.40%-- 
IOVAIovance Biotherapeutics3.44-0.26-7.03%-- 
TOVXTheriva Biologics Inc0.358801+0.020101+5.93%0.09PE
OCGNOcugen1.695-0.075-4.24%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed toaddress neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.